New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform OXFORD, UK -- iotaSciences, the Oxford-based leader in single-cell biology handling solutions has successfully raised an equity round in new growth funding to continue expansion of its pioneering business related to single-cell biology [...]

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce the launch of the Leo™ System. This next-generation Simple Western™ instrument offers higher throughput, flexibility, and efficiency over the current Jess™ and Abby™ Simple Western Systems. This state-of-the-art instrument enables simultaneous processing of up to 100 samples in a single 3-hour run, allowing scientists to process more samples [...]

VANCOUVER, British Columbia -- STEMCELL Technologies has commercially launched the CellPore™ Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the development of novel cell therapies to cure diseases. The CellPore™ Transfection System represents a substantial leap forward for cell engineering researchers, offering a novel method—known as mechanoporation—for cargo delivery [...]

Cambridge, UK – bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, today announces the appointment of Przemek Obloj as Chief Financial Officer. Mr. Obloj will oversee the company’s financial strategy, including fundraising, and work closely with Founder and CEO, Mark Kotter, and the Executive Team [...]

MasterKey™ enhances accuracy with a database built from years of discovery proteomics, providing detailed protein insights, with new proteins added monthly. MasterKey™ enables researchers to customize protein selection from a vast database, selecting 50+ proteins for quantitative multiplex assays. MasterKey™ leverages advanced mass spectrometry and the validated InoKey™ workflow to ensure precision and reliability in [...]

Alex Kim, Chief Operating Officer and Standard BioTools Co-Founder, to Serve as interim Chief Financial Officer Following Departure of Jeffrey Black on August 31, 2024 Industry Veteran Sean Mackay Named Chief Business Officer SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that Jeffrey Black, Chief Financial Officer, will resign [...]

SEATTLE -- TwinStrand Biosciences today announced an agreement with Exact Sciences (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, to exclusively license its patent estate in the cell free nucleic acid sequencing space, including its patent portfolios licensed from the University of Washington and the University of Texas Southwestern. The license is related to TwinStrand Duplex Sequencing® error-correction [...]

Analytical Technologies Group ("ATG" or the "Company"), a portfolio company of Reynolda Equity Partners ("Reynolda"), has acquired Tritech Field Engineering ("Tritech"). Based in Providence, RI, ATG provides service, maintenance and repair for biopharmaceutical laboratory instruments utilized primarily in pharmaceutical, biotech and university laboratories. ATG services a variety of devices playing a c ritical role in [...]

Oxford Instruments Andor, a world leader in scientific imaging solutions, today announces the launch of Dragonfly 400 and new VLE (Versatile Laser Engine), further expanding the award-winning Dragonfly confocal microscopy portfolio. The expansion of the range, which now comprises Dragonfly 200, 400 and 600, provides life science researchers and industry partners with tailored solutions that [...]

CHARLOTTESVILLE, Va. -- LumaCyte, a trailblazer in advanced label-free cellular bioanalytical technology and instrumentation, proudly announces the launch of the Laser Force Cytology™ Academy—an interactive library of comprehensive training courses designed to deepen understanding of LumaCyte’s transformative Laser Force Cytology™ (LFC™) optical force technology. This new offering from LumaCyte aims to empower scientists and biomanufacturers [...]